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Adding a flap on the top of an insecticide-treated bednet helps to 10 
intercept blood-seeking mosquitoes, and allows a wider range of 11 
insecticides to be used together.    Net-buyers must now make a 12 
challenging decision for each target area: which net-product will be 13 
most cost-effective, given the resistance in the local vectors?      14 
(274 words) 15 
 16 
Main text 17 
The technology of LLINs – long-lasting insecticidal nets - has been remarkably successful, 18 
however you measure success.    A series of field-trials in the 1990s demonstrated that 19 
insecticide-treated nets were remarkably effective at preventing all-cause mortality in under-20 
five children, and a subsequent economic analysis showed that they were as cost-effective as 21 
measles vaccine, as a child-survival intervention1.     This was remarkable, because at the time, 22 
measles vaccine was regarded as a gold standard of cost-effectiveness.   It led to massive 23 
investment in increasing coverage, through the Global Fund, the President’s Malaria Initiative, 24 
and UNICEF2.   In Africa, coverage has increased from less than 2% in the year 2000 to more 25 
than 50% by 20173, and a project tracking LLIN supplies to malaria control programmes recently 26 
announced the delivery of the two-billionth LLIN4.   This scaling-up, together with 27 
standardisation of designs and sizes, has contributed to a reduction in the mean unit price of a 28 
conventional pyrethroid-treated LLIN, which has come down from about USD$4.50 in 2006-9 to 29 
about $2.50 per LLIN in 2013-65.    Nevertheless, LLINs remain the largest single item in most 30 
malaria budgets: for example, the commodity costs of LLINs represented more than 42% of the 31 
total expenditure on malaria by the Global Fund in 20102.    32 
 33 
The resulting public health impact has been equally impressive.  According to WHO, the scaling 34 
up of coverage of modern malaria interventions from 2000 to 2015 prevented approximately 35 
six million deaths due to malaria, mostly among young children in tropical Africa6.   A separate 36 
analysis found that LLINs were responsible for the bulk of the decline in malaria burden during 37 
the same period:  68% was due to LLINs, the remainder to other forms of vector control, 38 
improved drugs and case management, etc.7.         39 
 40 
However, increased coverage also had another effect: it accelerated the evolution of insecticide 41 
resistance in the African vectors.  Resistance is present widespread, and in some places, the 42 
dose needed to kill the local mosquitoes is now several hundred-fold higher than it would be in 43 
the absence of resistance8.  In the African region, insecticide resistance is by far the most 44 
dangerous threat facing malaria control: the achievements described above are at risk and 45 
could be lost.     46 
In response to this threat, the WHO developed the ‘GPIRM’, the Global Plan for Insecticide 47 
Resistance Management in malaria vectors.    The GPIRM offers strategic recommendations 48 
about how to deploy products containing new non-pyrethroid insecticides, alone or in 49 
combination with conventional pyrethroids, in order to preserve susceptibility and slow down 50 
the evolution of resistance.   The first problem is finding non-pyrethroid insecticides that are 51 
both safe and effective as a net-treatment.    Some well-known insecticides, developed 52 
originally for agriculture, are effective enough against the mosquitoes, but too toxic to be used 53 
in fabric that will surround sleeping children, and lie in close contact with their faces9.    A clever 54 
idea to address this problem has been investigated by Murray et al, and their findings are 55 
reported in this issue of Nature Microbiology10.  56 
This idea arises from previous studies, carried out by Phillip McCall’s team in the Liverpool 57 
School of Tropical Medicine.  They used video to describe how female mosquitoes approach a 58 
mosquito-net with a person inside.  These studies suggested that the approach route is typically 59 
downward from above: the mosquito makes initial contact with the roof, and then tracks 60 
sideways across the roof.  Their simple innovation was to attach a vertical flap or baffle of 61 
netting to the roof of the net, which acts as a barrier to, and therefore tends to be contacted 62 
by, insects tracking sideways across the top of the net (Figure 1).  McCall and colleagues 63 
painstakingly identified the most cost-effective size, shape and orientation, and then compared 64 
the performance of the modified nets to that of ordinary nets in experimental huts.   It was 65 
observed that the addition of a barrier treated with fenitrothion (an organophosphate) to an 66 
ordinary pyrethroid-treated LLIN produces a substantial increase in the proportion of female 67 
mosquitoes that are killed as they seek a meal inside the experimental hut.    The researchers 68 
then used this data to predict that if the new design nets were deployed, and if the 69 
performance-improvements in ordinary houses were as good as those seen in experimental 70 
huts, then substantial epidemiological benefits would be expected. 71 
Some caveats must be mentioned.   Experimental huts try to replicate the conditions in 72 
ordinary houses, but they do so imperfectly.    In particular, it seems possible that horizontal air 73 
movement in ordinary houses may be both larger and more variable than in experimental huts.    74 
Also, it would probably be preferable to use a different insecticide: there are other 75 
organophosphates that are less malodorous and have a better reputation for safety in practical 76 
spraying programmes.    Moreover, nets are often taken down for washing, and may be used as 77 
a sheet for sleeping on or under, leading to at least some direct contact with the insecticide on 78 
the barrier.  There would have to be a formal risk assessment, using WHO-recommended 79 
methods, to take such additional exposures into account.   80 
The evolution of LLINs, as a technology, has so far been relatively simple.    Stage 1 was the ITN, 81 
the insecticide-treated net, which was treated in the field by dipping in an emulsion of 82 
insecticide.   Unfortunately, ITNs need to be re-dipped annually, and in practice, this rarely 83 
happened.   The first LLINs, which were designed to last 3 years without the need for re-84 
treatment, appeared in the early 2000s.   WHO soon developed standards and specification to 85 
define what an LLIN is, and it then suggested that public health agencies should give up ITNs 86 
and buy only WHO-recommended LLINs.  Since these standards were fixed, there has been 87 
conspicuously little further technological evolution in LLIN design.    With most paradigm-88 
changing technologies, the process of becoming widely adopted is accompanied by rapid and 89 
substantial technical evolution, through incremental improvement and adaptation.   In the case 90 
of LLINs, this process seems to have been constrained.           91 
The Global Fund is the most important buyer of LLINs2.  It relies on WHO for all technical 92 
matters, and its procurement process has no technical content.  It therefore treats all WHO-93 
recommended nets as identical, although some nets perform better than others.  Durability is a 94 
conspicuous example:  it is a key determinant of cost-effectiveness, and more cost-effective 95 
LLINs, that are slightly more expensive per unit but much more long-lasting, could certainly be 96 
developed.   Yet manufacturers who tried to introduce such products (e.g. Bayer’s Lifenet7) 97 
found no interest among institutional buyers.  Thus, any new technical advance in net design 98 
must consider the way in which it can win market-share.   The WHO does test new LLINs, 99 
comparing each new product with a set of minimum standards.   However, these methods do 100 
not take any account of insecticide resistance, and there is no system to compare products with 101 
other.   102 
A range of LLIN products, with new active ingredients, are now arriving on the scene.  Most 103 
come with a higher price but also impressive claims of improved performance.   The arrival of 104 
nets with roof-barriers, containing yet more insecticides, could make this range considerably 105 
wider.   This is of course a very good thing from the point of view of resistance management, 106 
but it means that buyers will now face a new and bewilderingly complex choice: which product 107 
to buy for given target area?    A further dimension of complexity comes from fact that the 108 
relative cost-effectiveness of alternative products depends on the resistance in the local 109 
vectors, and this also varies, both geographically and between species.   Therefore, 110 
procurement decisions will need to be tailored to the local situation, and informed not only by 111 
evidence on the characteristics of alternative products, but also by data on local resistance.   112 
The system used to make such decisions will determine the future technological evolution of 113 
LLINs.    However, decisions of this kind are currently not within the mandates of either the 114 
WHO or the Global Fund.     115 
The roof barriers on nets studied by Murray et al are clearly a good idea, but before they can 116 
become widely used, we will have to see some shift in the structures and processes by which 117 
donor-funded agencies choose which net to buy for a given target area.      118 
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Figure legend 126 
 127 
Figure 1.  This new bednet design improves the performance of long-lasting insecticidal nets, 128 
and enables the use of new combinations of insecticides.   A vertical flap containing insecticide 129 
is attached to the roof of standard nets, to intercept blood-seeking female mosquitoes 130 
attracted by the odour of, and searching for access to, the person sleeping inside the net.    131 
 132 
(54 words, 362 characters).    133 
 134 
 135 
References  136 
1.  Goodman CA, Coleman PG, Mills AJ.   Cost-effectiveness of malaria control in sub-Saharan 137 
Africa.  Lancet. 1999 Jul 31;354(9176):378-85. 138 
 139 
 140 
2.   World Health Organisation, World Malaria Report 2011 141 
 142 
3.   World Health Organisation, World Malaria Report 2018  143 
 144 
4.  http://allianceformalariaprevention.com/working-groups/net-mapping-project/.   Accessed 145 
20/11/2019.  146 
 147 
5.  https://www.unicef.org/supply/files/6_BMGF_CHAI_update_next_generation.pdf.  Accessed 148 
20/11/2019 149 
 150 
6.  World Health Organisation, World Malaria Report 2016 151 
 152 
7.  Bhatt et al 2016   The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 153 
2015.   doi: 10.1038/nature15535. Epub 2015 Sep 16. 154 
 155 
8.   Toé KH, Jones CM, N’Fale S, Ismail HM, Dabiré RK, and Ranson H. (2014). Increased Pyrethroid 156 
Resistance in Malaria Vectors and Decreased Bed Net Effectiveness, Burkina Faso.  Emerg Infect Dis. 157 
2014 Oct; 20(10): 1691–1696. 158 
 159 
9. Barlow SM1, Sullivan FM, Lines J.(2001).  Risk assessment of the use of deltamethrin on bednets for 160 
the prevention of malaria.   Food Chem Toxicol. 2001 May;39(5):407-22 161 
 162 
10.  Murray et al [production to update, NMicrobiol 10.1038/s41564-019-0607-2] 163 
  164 
 165 
 166 
